Navigation Links
MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting

MGI PHARMA Summarizes Data Presented at the

2007 American Society of Clinical Oncology (ASCO) Annual Meeting

--Dacogen(R) Activity in Older Patients with AML and in Refractory

ALL Patients Presented--

--Differentiation of the molecular interaction of Aloxi(R) with

the 5-HT3 Receptor Reported--

--Results of a Survival Analysis of Glioblastoma Patients Treated

with Multimodal Therapy, including Gliadel(R) Described--

--Survival Analysis of Irofulven in Second-Line HRPC Patients

Presented--

CHICAGO---June 4, 2007--MGI Pharma, Inc. (Nasdaq:MOGN), a biopharmaceutical company focused in oncology and acute care, today provided highlights of data presentations made during the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting. Dacogen (decitabine) for Injection was the subject of five posters including the presentation of efficacy data in older patients with acute myelogenous leukemia (AML) and activity observed in patients with refractory acute lymphocytic leukemia (ALL). Gliadel(R) Wafer (polifeprosan 20 with carmustine implant) was the subject of two posters with one detailing the impact of multimodal therapy that included Gliadel implantation, followed by treatment with radiation and concurrent temozolomide plus rotational chemotherapy, on survival in patients with primary glioblastoma. A poster discussion provided updated response and survival data from a randomized phase 2 clinical trial of Irofulven (MGI 114; hydroxymethylacylfulvene) in hormone refractory prostate cancer (HRPC) patients who failed docetaxel treatment. In addition to two posters, Aloxi(R) (palonosetron

hydrochloride) Injection was the subject of a published abstract describing study results that differentiate the molecular interaction of Aloxi with the 5-HT3 receptor. These data provide new insight into the receptor binding mechanisms that may explain the
'"/>




Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:1/23/2015)... , Jan. 23, 2015  Now available for sale, The ... support that prevents ankle sprains by cushioning the ankle ... fits securely around the outside of any shoe type ... comfort while still offering protection against sprains. With customers ...
(Date:1/23/2015)... Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), ... extracorporeal cytokine adsorber to reduce deadly inflammation in ... of $385,642, net of transaction costs, in non-dilutive ... Business Tax Certificate Transfer Program sponsored by the ...
(Date:1/22/2015)...  ViewRay™, a privately held medical device company, announced today ... with ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to ... of cancer in Japan . ViewRay,s ... and only MRI-guided radiation therapy system that images and ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
... announces that a new market research report is ... Global Medical Imaging Equipment Services Industry ... report analyzes the worldwide markets for Medical Imaging ... Product segments: OEM (Original Equipment Manufacturer), and Other ...
... NEW YORK, Feb. 23, 2011 Reportlinker.com announces ... in its catalogue: Global ... http://www.reportlinker.com/p092536/Global-Hematology-Instruments-and-Reagents-Industry.html This report ... Reagents in US$ Million by the following Product ...
Cached Medicine Technology:Reportlinker Adds Global Medical Imaging Equipment Services Industry 2Reportlinker Adds Global Hematology Instruments and Reagents Industry 2
(Date:1/22/2015)... The federal court overseeing thousands of vaginal mesh ... District of West Virginia has upheld a $2 million verdict ... trial. In an Order dated January 21st, the Court denied ... C.R. Bard had not proven a miscarriage of justice. (Cisson ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of Cruz Chiropractic ... treated just about every type of injury that can result from ... same twenty-plus years, the team at Doctors on Liens ... possible doctor. With the combined breadth of experience between ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne ... highest annual revenues in the past three years. Today, the ... dresses. , According to the sales manager of the company, ... them in 2015. This point can be reflected on the ...
(Date:1/22/2015)... As interest in the value of spiritual support ... Rev. Eric J. Hall , president and CEO of ... be the keynote speaker on January 27 at an international ... , The conference, “Hope and Resilience: Innovative and Interdisciplinary Spiritual ...
(Date:1/22/2015)... USA (PRWEB) January 22, 2015 State ... statewide data management system with support from GEOSYSTEMS, a ... The new solution will leverage Hexagon Geospatial’s ERDAS ... vector data as well as point clouds and documents. ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... M. Jackson Foundation for the Advancement of Military Medicine, ... anesthesiology residents in the art and science of advanced ... aim is to serve as a resource to manage ... Military Advanced Regional Anesthesia and Analgesia Handbook " is ...
... Net and Elderly Care in Underserved Communities , ... announced today that it has approved more than 400 ... first quarter of 2009. The not-for-profit health care organization,s ... care in the safety net and improving care for ...
... promoting a painless new method for detecting diabetes, ... at the American Association of Clinical Endocrinologists (AACE) ... Texas.(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b ... diabetes, doctors examined the saliva of 40 different ...
... Non Dues Revenue for the Texas Medical ... launched MedBuzz, a powerful new online advertising ... Medical Association that has extended TMA,s online ... generated incremental non-dues revenue for the largest ...
... April 28 MinuteClinic, the pioneer and largest ... States, announced that it has become a participating ... insurer in Pennsylvania based on membership.Members of Highmark,s ... care centers located inside select CVS/pharmacy stores in ...
... SARS, and true severity of outbreak still unknown , , TUESDAY, April ... flu in Mexico rises and new cases appear in the United ... sense of mounting dread. , But experts in influenza and infectious ... still far from certain. , "This is something of concern [but] ...
Cached Medicine News:Health News:HJF publishes handbook on managing pain of battlefield trauma 2Health News:Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009 2Health News:Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009 3Health News:Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009 4Health News:Detecting Diabetes Without a Needle: The Spit Factor 2Health News:Audience Generation, LLC Launches MedBuzz for Texas Medical Association 2Health News:Audience Generation, LLC Launches MedBuzz for Texas Medical Association 3Health News:MinuteClinic Becomes Participating Provider With Highmark Inc. 2Health News:MinuteClinic Becomes Participating Provider With Highmark Inc. 3Health News:Experts Say Panic Over Swine Flu Is Premature 2Health News:Experts Say Panic Over Swine Flu Is Premature 3Health News:Experts Say Panic Over Swine Flu Is Premature 4Health News:Experts Say Panic Over Swine Flu Is Premature 5
Iron FS Ferene for determination of iron in serum. Available with Calibrator: Trucal U and Controls: Trulab N, Trulab P. For automated systems....
For the quantitative determination of iron, total iron-binding capacity in human serum....
... of HDL-cholesterol in serum and ... immunochemical inhibition of non-HDL-lipoproteins. Excellent ... Endpoint assay. Unaffected by interfering ... Available with calibrator: Trucal HDL/LDL ...
HDL Cholesterol (PEG) Precip. Reagent + 5 ml of 50 mg/dl cholesterol std....
Medicine Products: